Cue Health (HLTH) Stock Price, News & Analysis

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cue Health in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HLTH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLTH, but not buy additional shares or sell existing shares.
View HLTH analyst ratings or view top-rated stocks.

2 equities research analysts have issued 1 year price objectives for Cue Health's stock. Their HLTH share price targets range from $3.00 to $3.00. On average, they predict the company's share price to reach $3.00 in the next twelve months. This suggests a possible upside of 1,967.5% from the stock's current price.
View analysts price targets for HLTH or view top-rated stocks among Wall Street analysts.

Cue Health's stock was trading at $0.1625 at the beginning of 2024. Since then, HLTH shares have decreased by 10.7% and is now trading at $0.1451.
View the best growth stocks for 2024 here.

Cue Health saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 563,500 shares, a drop of 22.9% from the March 15th total of 730,600 shares. Based on an average daily volume of 519,600 shares, the short-interest ratio is presently 1.1 days. Currently, 0.5% of the shares of the stock are short sold.
View Cue Health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our HLTH earnings forecast.

Cue Health Inc. (NASDAQ:HLTH) released its quarterly earnings results on Wednesday, March, 13th. The company reported ($0.32) EPS for the quarter, beating analysts' consensus estimates of ($0.45) by $0.13. The business had revenue of $18.80 million for the quarter, compared to analyst estimates of $17.60 million. Cue Health had a negative trailing twelve-month return on equity of 67.82% and a negative net margin of 526.48%.

Cue Health issued an update on its first quarter 2024 earnings guidance on Wednesday, March, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $9.0 million-$11.0 million, compared to the consensus revenue estimate of $28.9 million.

Cue Health (HLTH) raised $200 million in an initial public offering on Friday, September 24th 2021. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share.

Shares of HLTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.